Convalescent plasma for the treatment of severe COVID-19: Updates on the efficacy and safety
6 min41
Frequent headaches while looking at the screen.....
Frequent headaches while looking at the screen.....
Frequent headaches while looking at the screen.....
Frequent headaches while looking at the screen.....
Frequent headaches while looking at the screen.....
Lorem ipsum dolor sit amet, consectetur adipiscing
elit, sed
do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
ad minim
veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
commodo
consequat.
Duis aute irure dolor in reprehenderit in voluptate
velit esse
cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
cupidatat non
proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
The scarcity of the
approved curative agents for coronavirus disease (COVID-19) has led to a fast
implementation of convalescent plasma therapy (CPT) in several countries.
A phase IV, non-randomized, multicenter, open-label, uncontrolled, multi-country study was carried to investigate the safety and efficacy of dexlansoprazole mod...
You want to delete this comment?Please mention commentInvalid Text ContentText Content cannot me more than 1000Something Went WrongCancelConfirmConfirm DeleteHide RepliesViewRepliesView Repliesuaenru
Try:
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.
Comments (0)